According to Marinova managing director Paul Garrott the product is environmentally as well as commercially sustainable now. The next step would be to manufacture in a large scale. He hopes human trials will commence soon. He expressed hope that this could find use in other pharmaceutical and medical devices. It is ready to go. The commercial potential is enormous in nutritional supplements, hand washes and nasal delivery products which target the spread and prevention of viral conditions We believe that this is the only natural certified organic substance that has this level to inhibit swine flu It is not a substitute for the swine flu vaccination, rather it is a first defense against swine flu It is conceivable that there could be a product on the market within months, he said.

Dr. Fitton agreed that there was a growing market for naturally derived products. She added that this product was stable, water soluble and has an extended shelf life that makes it suitable for inclusion in a wide range of delivery systems, like hand wash. The company has already applied for a patent.